GH

Guardant Health Inc.

Price

$169.42

return (12m)

189.26%

p/e

-46.35

p/bv

-94.29

DIVIDEND YIELD

0.00%

GH price

Guardant Health

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.34%

3 months

43.56%

1 year

189.26%

2 years

496.97%

5 years

65.66%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals GH

Valuation

P/E

-46.35

Sector -2.19

Industry 1.21

P/BV

-94.29

Sector 2.22

Industry 2.11

P/Revenue (PSR)

17.76

Sector 2.01

Industry 0.78

EV/EBITDA

-180.97

Sector -17.81

Industry -25.30

EV/EBIT

-180.97

Sector -26.72

Industry -18.04

P/EBITDA

-48.85

Sector 0.36

Industry 0.18

P/EBIT

-46.74

Sector -3.34

Industry 1.26

P/Total Assets

10.99

Sector 1.23

Industry 0.86

P/Net Current Assets

-27.27

Sector -27.35

Industry -12.37

P/Working Capital

20.49

Sector -4.54

Industry -49.48

EPS

-3.41

Sector -0.87

Industry -0.55

BVPS

-1.68

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

65.01%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-35.41%

Sector -323.65%

Industry -73.39%

EBIT Margin

-35.41%

Sector -194.57%

Industry -11.94%

Operating Margin

-39.75%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-38.32%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.18

Sector 0.12

Industry 0.22

Profitability

ROE

203.45%

Sector -33.82%

Industry -37.56%

ROA

-23.71%

Sector -29.63%

Industry -17.56%

ROIC

-73.75%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.03

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-3.79

Sector -1.47

Industry -31.86

Net Debt / EBIT

-3.79

Sector -1.32

Industry 2.06

Net Debt / Equity

-2.02

Sector -0.35

Industry 0.14

Gross Debt / Equity

-6.74

Sector 0.14

Industry 0.51

Equity/Assets

-0.12

Sector 0.42

Industry 0.25

Liabilities/Assets

1.12

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

25.92%

Sector -

Industry -

5Y Earnings CAGR

2.25%

Sector -

Industry -

Fundamentals GH

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
GH Guardant Health Inc.	$169.42	189.26%	0.00%	-46.35	-94.29	203.45%	-38.32%
LLY Eli Lilly and Compay	$1,263.67	80.67%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$392.40	-18.11%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.27	-6.25%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$157.47	28.47%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$629.40	26.86%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$115.18	-11.04%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$93.55	7.43%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.32	38.07%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.72	36.23%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$50.55	-51.28%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.42	-23.85%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$559.65	-12.10%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$232.30	-17.73%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$218.22	3.99%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.14	1.77%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$284.14	223.77%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.67	4.30%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$338.99	-11.95%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$14.95	5.43%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Guardant Health

Guardant Health Inc.

Average Investor10 user rating

4.0 (3 people)

United States

15 years

Founded: 2011

2018

Time since IPO - 8 years

864

Employees

Guardant Health Inc. (United States) is listed on the Nasdaq and has a market capitalization of $21.02 billion, with shareholders equity totaling $-222.87 million.

The company employs approximately 864 people and operates in the Health sector, within the Health Services and Providers industry.

Over the past 12 months, Guardant Health Inc. reported $1.18 billion in revenue, generating net income of $-453.43 million.

Key financial metrics include a P/E ratio of -46.35, a price-to-book (P/B) ratio of -94.29, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker GH.

Market cap

$21.02 billion

Net worth

$-222.87 million

$-222,870,000.00

Assets

$1.91 billion

$1,912,290,000.00

Total Shares Outstanding

133.00 million

133,000,000

Average Daily Trading Volume

$2.67 million

$2,667,617.34

Sector

Health

Industry

Health Services and Providers

GH revenue and profits

Financial Results GH

DRAG THE FRAME TO SEE MORE DATA

GH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.72 36,52% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$276.00 --6,86% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.41 119,06% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$381.45 33,44% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.27 --6,88% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,263.67 79,56% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.14 --0,09% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$157.47 26,15% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87